Health and Healthcare Systems

Obstacles still exist for women in science, but this young researcher is breaking the mould

Kaitlyn Sadtler young global leaders World Economic Forum immunologist bioengineer National Institutes of Health

Kaitlyn Sadtler is an immunologist and bioengineer at the National Institutes of Health, just outside of Washington, D.C., in the US, and one of the Forum's Young Global Leaders. Image: TED.com

Lukas Bester
Writer, Forum Agenda
  • Kaitlyn Sadtler is an immunologist and bioengineer at the National Institutes of Health, just outside of Washington, D.C., in the US.
  • Her team is currently developing a model to evaluate the body’s response to injury.
  • They have re-invigorated their work on traumatic injury and how the immune system can promote healing and tissue regeneration.

Dr Kaitlyn Sadtler is an immunologist and bioengineer at the National Institutes of Health, just outside of Washington, D.C., in the US. Growing up in rural Maryland, not far from where she works now, she’s always been fascinated with puzzles and problem-solving. She attributes this to ultimately leading her to pursue science - a field that, according to her, is essentially one giant puzzle.

Even though she considered careers in policy, diplomacy, and communication, her love for the process of discovery always drew her back to the laboratory. She also enjoys training the next generation of scientists and leading them beyond the current frontiers. We spoke to Kaitlin about her career and her experiences being a leader in her team.

Loading...

What does your current position entail and what have been your greatest successes and challenges?

In the US academic system, a large part of the work necessitates applying for grants and keeping your head above the water. The position as Chief of the Section at the NIH provides me with the intellectual freedom and flexibility to focus on the science and enjoy the accompanying innovation and excitement without having to work through grant systems, which in turn allows for more time to train young scientists.

As the head of a laboratory, my duties range from balancing budgets to filling out paperwork, teaching my students new techniques, and facilitating the design and interpretation of experiments.

Our lab is diverse, and diversity drives innovation, and we have made several advances in immunology, both in COVID-19 research in wound healing after traumatic injury. However, the greatest challenges lie outside of the experiments.

When cultivating an inclusive environment as a young woman in science, it becomes imperative that I confront my own biases to drive personal change before implementing those changes to defend those who cannot stand up for themselves. At the same time, I am continuously working through obstacles that still exist for women in STEM. There are days when I feel I must justify that I am here because of my contributions as an accomplished researcher and a capable leader, not because I am simply ticking a box as a female engineer. Unfortunately, even if I do everything right, there are days when I will still lose.

Discover

What is a YGL?

What are you currently working on?

In finalizing some of our COVID-19 research, we have had the chance to re-invigorate our work on traumatic injury and how our immune system can promote healing and tissue regeneration.

Recently, we posted new research on our immune cells’ astonishing ability to refrain from attacking our bodies during injury. As our immune system tries to fight off bacteria, it also has to know not to attack our tissues. Through our studies, we identified a cell type previously described in cancer that was critical in regulating immune responses during trauma and without which there was extensive tissue damage past the initial injury. We are leveraging this finding to design new therapeutics, from wound healing to medical device development.

How did COVID-19 change your approach to work as a scientist?

For me, the COVID-19 pandemic undoubtedly underscored how vitally important scientific communication and openness in data sharing are. Communication with the public about what we do in the lab, using language that everyone understands, will encourage input from non-scientists and lead to better public insight into the potential for new frontiers in research and medicine.

As one of the Forum's young global leaders, how has the community impacted your work?

Although I have just started in the Young Global Leader community, I have already had the privilege to meet people who have directly impacted my work.

One example is when I searched for members to join my laboratory, and a fellow Young Global Leader approached me. They shared that they were working with a talented medical student in Ghana and that she was interested in getting a year of research experience before completing her clinical work. It sounded like a perfect fit, and she is joining our group this fall for a year-long research fellowship.

Learn more about the Forum of Young Global Leaders here.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

Health and Healthcare

Share:
The Big Picture
Explore and monitor how Health and Healthcare is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

COPD kills more than lung and breast cancer combined. It's time to change that

Nitin Kapoor

November 22, 2024

A historic leap in cancer vaccines – here’s what you need to know

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum